Westend S.A.
- SEC CIK
- 0001283968
In the past year, 1 open-market purchase filing worth $2.00M and 1 sale filing worth $270.9M.
Current role at each company
- CAVA Cava Group, Inc.Directoras of Jun 17, 2026
- LXRX Lexicon Pharmaceuticals, Inc.Director, 10% Owneras of May 8, 2026
- SRRK Scholar Rock Holding Corp10% Owneras of Oct 16, 2023
- WW WW International, Inc.10% Owneras of May 11, 2023
- CBIO Crescent Biopharma, Inc.10% Owneras of Feb 28, 2023
Show 1 more company
- OMGA Omega Therapeutics, Inc.10% Owneras of Aug 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.00M
- 1 filing
- Sold
- $270.9M
- 1 filing
- Net
- −$268.9M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Westend S.A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAVA Cava Group, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing)4:15 PM ET | Jun 15 | 2 days | Artal Group S.A. and 6 othersDirector | SSale | −3.00M | $90.30 | −$270.9M | −31.6%6.51M after | |
| Nov 20, 2024 (view filing)4:30 PM ET | Nov 18 | 2 days | Artal Group S.A. and 5 othersDirector | SSale | −8.00M | $134.13 | −$1.07B | −45.7%9.51M after | |
| Aug 28, 2024 (view filing)4:30 PM ET | Aug 26 | 2 days | Artal Group S.A. and 5 othersDirector, 10% Owner | SSale | −6.00M | $116.36 | −$698.2M | −25.5%17.5M after | |
| Jun 7, 2024 (view filing)4:30 PM ET | Jun 5 | 2 days | Artal Group S.A. and 5 othersDirector, 10% Owner | SSale | −3.00M | $87.25 | −$261.8M | −11.3%23.5M after | |
| Mar 25, 2024 (view filing)4:15 PM ET | Mar 21 | 4 days | Artal Group S.A. and 5 othersDirector, 10% Owner | SSale | −2.00M | $66.25 | −$132.5M | −7.0%26.5M after | |
| Feb 29, 2024 (view filing)4:16 PM ET | Feb 27 | 2 days | Artal Group S.A. and 5 othersDirector, 10% Owner | SSale | −3.50M | $53.60 | −$187.6M | −10.9%28.5M after |
LXRX Lexicon Pharmaceuticals, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 (view filing)4:25 PM ET | Feb 2 | 2 days | Debbane Raymond and 8 othersDirector | PPurchase | +1.54M | $1.30 | +$2.00M | New position1.54M after | |
| Jun 5, 2023 (view filing)4:46 PM ET | Jun 5 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +27.8M | $2.60 | +$72.2M | +54.6%78.6M after | |
| Aug 9, 2022 (view filing)4:46 PM ET | Aug 5 | 4 days | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +2.43M | $2.50 | +$6.07M | +5.0%50.9M after | |
| Aug 1, 2022 (view filing)4:15 PM ET | Aug 1 | Same day | Artal Group S.A. and 9 othersDirector, 10% Owner | PPurchase | +16.2M | $2.50 | +$40.4M | +50.1%48.4M after |
SRRK Scholar Rock Holding Corp
10% Owner6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 (view filing)5:46 PM ET | Oct 12 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +2.20M | $6.86 | +$15.1M | +24.3%11.3M after | 2 lots |
| May 2, 2023 (view filing)9:00 PM ET | Apr 28 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +31.6K | $6.43 | +$202.8K | +0.3%9.06M after | |
| Jan 11, 2023 (view filing)8:30 PM ET | Jan 9 | 2 days | Artal Group S.A. and 7 others10% Owner | SSale | −1.09K | $9.48 | −$10.4K | 0.0%9.03M after | |
| Jan 9, 2023 (view filing)5:22 PM ET | Jan 5 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +48.8K | $9.33 | +$455.1K | +0.5%9.03M after | |
| Oct 27, 2022 (view filing)4:36 PM ET | Oct 25 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +130.3K | $8.04 | +$1.05M | +1.5%8.98M after | |
| Oct 7, 2022 (view filing)4:30 PM ET | Oct 3-4 | 4 daysLate | Artal Group S.A. and 7 others10% Owner | PPurchase | +100.0K | $7.60 | +$759.5K | +1.1%8.85M after | 2 lots |
WW WW International, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2023 (view filing)5:37 PM ET | May 10 | 1 day | Artal Luxembourg S. A. and 6 others10% Owner | SSale | −14.8M | $7.15 | −$106.0M | −100.0%0 after |
CBIO Crescent Biopharma, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 (view filing)5:33 PM ET | Feb 24 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +100.0K | $1.70 | +$170.0K | +1.2%8.59M after | |
| Feb 23, 2023 (view filing)6:23 PM ET | Feb 21-23 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +400.0K | $1.78 | +$712.3K | +4.9%8.49M after | 3 lots |
| Feb 17, 2023 (view filing)5:29 PM ET | Feb 15-17 | 2 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +1.52M | $2.00 | +$3.03M | +23.1%8.09M after | 3 lots |
| Feb 13, 2023 (view filing)5:45 PM ET | Feb 9 | 4 days | Artal Group S.A. and 7 others10% Owner | PPurchase | +11.5K | $3.24 | +$37.1K | +0.2%6.57M after |
OMGA Omega Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing)5:16 PM ET | Jul 30-Aug 3 | 4 days | Artal Group S.A. and 8 others10% Owner | PPurchase | +950.0K | $16.93 | +$16.1M | +71.8%2.27M after | 2 lots |